Schonfeld Strategic Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-382,233
| Closed | -$50.4M | – | 2726 |
|
|
2025
Q1 | $50.4M | Buy |
382,233
+361,693
| +1,761% | +$45.1M | 0.34% | 35 |
|
|
2024
Q4 | $1.72M | Sell |
20,540
-197
| -0.9% | -$16.2K | 0.01% | 892 |
|
|
2024
Q3 | $1.52M | Sell |
20,737
-113,717
| -85% | -$8.55M | 0.01% | 1009 |
|
|
2024
Q2 | $9.21M | Buy |
134,454
+110,036
| +451% | +$7.63M | 0.07% | 371 |
|
|
2024
Q1 | $1.69M | Sell |
24,418
-141,703
| -85% | -$9.74M | 0.01% | 1050 |
|
|
2023
Q4 | $11.9M | Buy |
+166,121
| New | +$9.56M | 0.1% | 300 |
|
|
2022
Q4 | – | Sell |
-32,071
| Closed | -$1.49M | – | 3089 |
|
|
2022
Q3 | $1.49M | Sell |
32,071
-31,130
| -49% | -$1.63M | 0.01% | 1025 |
|
|
2022
Q2 | $3.61M | Sell |
63,201
-34,724
| -35% | -$1.97M | 0.04% | 561 |
|
|
2022
Q1 | $5.99M | Buy |
97,925
+76,210
| +351% | +$3.96M | 0.07% | 391 |
|
|
2021
Q4 | $1.14M | Buy |
+21,715
| New | +$912K | 0.01% | 874 |
|
|
2017
Q4 | – | Sell |
-131,980
| Closed | -$2.08M | – | 919 |
|
|
2017
Q3 | $2.08M | Buy |
+131,980
| New | +$1.94M | 0.19% | 154 |
|
|
2017
Q2 | – | Sell |
-30,989
| Closed | -$504K | – | 810 |
|
|
2017
Q1 | $504K | Buy |
+30,989
| New | +$448K | 0.05% | 365 |
|
|
2016
Q3 | – | Sell |
-11,871
| Closed | -$460K | – | 573 |
|
|
2016
Q2 | $460K | Buy |
+11,871
| New | +$427K | 0.1% | 240 |
|
Other funds holding ITCI
KIM
HNB